Summary
Boston Scientific Corporation (BSX) filed an 8-K on July 7, 2005, reporting on material agreements entered into on July 1, 2005. The primary focus of this filing is the approval of special accelerated equity incentive awards by the Compensation Committee of the Board of Directors. These awards are designed to aid in the retention of key executive committee members and senior management personnel. The awards consist of stock options and deferred stock units, both with a five-year vesting schedule beginning on July 1, 2007. The filing details the specific stock option and deferred stock unit grants for several named executive officers, including the Chief Financial Officer, Chief Technology Officer, and Chief Operating Officer. These grants are made under the company's 2003 Long-Term Incentive Plan and are contingent upon continued employment through the vesting dates. Investors should note that this filing primarily concerns executive compensation and retention strategies, with no new financial results or significant business operations updates.
Key Highlights
- 1Boston Scientific approved special accelerated equity incentive awards for executive and senior management on July 1, 2005.
- 2The awards are designed to enhance employee retention within key leadership positions.
- 3Grants include Non-Qualified Stock Options with a five-year vesting period, starting July 1, 2007.
- 4Grants also include Deferred Stock Units, to be issued in five equal annual installments beginning July 1, 2007.
- 5Specific awards are detailed for 12 named executive officers, including the CFO and COO.
- 6All awards are subject to continued employment with the company through the vesting dates.
- 7The awards are made under the Boston Scientific 2003 Long-Term Incentive Plan.